Werner Lilienblum
- Pharmacology top 0.5%
- Molecular Biology
- Health, Toxicology and Mutagenesis top 2%
- Cancer Research top 10%
- Oncology
- Co-authors
- Karl Walter BockH. PfeilHeidi FothJan G. HengstlerKlaus‐Michael WollinP.-J. KramerHermann SchweinfurthThomas Gebel
- Topics
- Pharmacogenetics and Drug Metabolism (16 papers)Carcinogens and Genotoxicity Assessment (9 papers)Drug Transport and Resistance Mechanisms (6 papers)
In The Last Decade
Werner Lilienblum
31 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 129
- Pharmacology 556
- Molecular Biology 434
- Health, Toxicology and Mutagenesis 389
- Cancer Research 255
- Oncology 223
Countries citing papers authored by Werner Lilienblum
This map shows the geographic impact of Werner Lilienblum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Werner Lilienblum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Werner Lilienblum more than expected).
Fields of papers citing papers by Werner Lilienblum
This network shows the impact of papers produced by Werner Lilienblum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Werner Lilienblum. The network helps show where Werner Lilienblum may publish in the future.
Co-authorship network of co-authors of Werner Lilienblum
This figure shows the co-authorship network connecting the top 25 collaborators of Werner Lilienblum. A scholar is included among the top collaborators of Werner Lilienblum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Werner Lilienblum. Werner Lilienblum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 92 | |
| 3 | 13 | |
| 4 | 273 | |
| 5 | 208 | |
| 6 | 66 | |
| 7 | 15 | |
| 8 | 5 | |
| 9 | 62 | |
| 10 | 9 | |
| 11 | 6 | |
| 12 | 12 | |
| 13 | 13 | |
| 14 | 37 | |
| 15 | 22 | |
| 16 | 8 | |
| 17 | 33 | |
| 18 | 16 | |
| 19 | 25 | |
| 20 | 19 |
About Werner Lilienblum
Werner Lilienblum is a scholar working on Pharmacology, Cancer Research and Biochemistry, having authored 31 papers that have together received 1.6k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (16 papers), Carcinogens and Genotoxicity Assessment (9 papers) and Drug Transport and Resistance Mechanisms (6 papers). The work is most often cited by research in Pharmacology (556 citations), Chemical Health and Safety (21 citations) and Health, Toxicology and Mutagenesis (389 citations). Werner Lilienblum has collaborated with scholars based in Germany and India. Frequent co-authors include Karl Walter Bock, H. Pfeil, Heidi Foth, Jan G. Hengstler, Klaus‐Michael Wollin, P.-J. Kramer, Hermann Schweinfurth, Thomas Gebel, Autar K. Walli and Regine Kahl. Their work appears in journals such as FEBS Letters, European Journal of Biochemistry and Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.